SF3B1 and myelodysplastic syndrome: In 4 of those samples the SF3B1 VAF was lower than 15% and therefore accounted to the 13 samples of the entire MDS cohort showing only one SF3B1 mutation with a low VAF (<15%; Fig. 3B).